ir

How a SARS patient's antibody binds to the COVID-19 virus

Structural data on the complex could guide drug and vaccine design




ir

Why the best material for a homemade coronavirus face mask is hard to identify

Variables in fabrics, fit, and user behavior can influence how well a mask might block the virus's spread




ir

US EPA advances rollbacks while coronavirus pandemic rages

Work continues on chemical risks, climate, and what data regulators may consider




ir

Coronavirus puts science to the test

A new generation of technologies being used for the diagnosis, treatment, and prevention of COVID-19 will be pressure tested amid a pandemic




ir

Virus weakens markets for renewable energy

Industries press pause on steep growth trajectory




ir

Merdad Parsey on building a case for remdesivir amid the coronavirus pandemic

Gilead's Chief Medical Officer talks about the challenges of clinical design in the time of COVID-19




ir

How susceptible is your cat or dog to the novel coronavirus?

Cats can transmit SARS-CoV-2 to one another, but the virus replicates poorly in dogs, pigs, chickens, and ducks, study finds




ir

GSK partners with Vir on COVID-19 therapies and with 3 companies on vaccines




ir

Air Liquide negotiates sale of hygiene unit




ir

Por que o melhor material para uma máscara facial caseira para o coronavírus é difícil de identificar

Variáveis em tecidos, ajuste e comportamento do usuário podem influenciar a eficácia com que uma máscara pode bloquear a propagação do vírus




ir

What do we know about the novel coronavirus's 29 proteins?

These biomolecules could hold clues to why the virus is so infectious and how to stop it




ir

Fujifilm tests favipiravir as COVID-19 treatment

Japanese government plans to buy at least 2 million tablets of the influenza drug




ir

What explains the non-respiratory symptoms seen in some COVID-19 patients?

Some patients experience neurological, cardiovascular, and intestinal symptoms after infection with SARS-CoV-2




ir

Disinfectant demand from coronavirus concerns challenges specialty chemical supply chain

As wipes and sprays sell out, quaternary ammonium compound makers try to keep up




ir

Fujifilm tests favipiravir as a COVID-19 treatment

Japanese government plans to buy at least 2 million courses of the influenza drug




ir

Novel coronavirus found in surprisingly high levels in sewage

Viral levels higher than expected based on confirmed COVID-19 cases




ir

How industrial gas firms are meeting demand for medical oxygen for COVID-19 patients

COVID-19 is driving a fivefold or greater increase in demand




ir

Consortia lend their supercomputers to fight COVID-19

National labs, universities, and companies around the world are fast-tracking proposals to use their high-performance computer resources against the novel coronavirus




ir

Adding the missing sugars to coronavirus protein structures

Most of the recently reported viral structures have left out the carbohydrate decorations that help mask the proteins from our immune system




ir

Vir taps Samsung to produce coronavirus candidate




ir

Kyowa Kirin invests in MEI Pharma's blood-cancer drug




ir

CAS curates data set of antiviral compound




ir

How one ACS division took its Philadelphia technical program virtual

Members of the Division of Colloid and Surface Chemistry presented 155 virtual talks over 3 days




ir

How susceptible is your cat or dog to the novel coronavirus?

Cats can transmit SARS-CoV-2 to one another, but the virus replicates poorly in dogs, pigs, chickens, and ducks, study finds




ir

Environmental toxicologist wants to understand how microplastics affect human health

Stephanie Wright of King's College London discusses what's known about microplastics and how much more there is to learn




ir

Scaling up remdesivir amid the coronavirus crisis

Manufacturing experts weigh in on Gilead's challenge in making its potential COVID-19 treatment




ir

Mercury move portends similar deregulation of air pollution by US EPA

Planned changes could mean weaker emission controls for chemical industry




ir

Scaling up remdesivir amid the coronavirus crisis

Manufacturing experts weigh in on Gilead's challenge in making its potential COVID-19 treatment




ir

Adding the missing sugars to coronavirus protein structures

Most of the recently reported viral structures have left out the carbohydrate decorations that help mask the proteins from our immune system




ir

Michelin partners with Enviro to recycle tires with pyrolysis




ir

Astellas acquires Nanna Therapeutics




ir

Fujifilm beefs up its favipiravir supply chain




ir

Merck KGaA ramps up viral vaccine and gene therapy manufacturing




ir

Takasago buys stake in pine chemicals firm




ir

Mercury move portends similar deregulation of air pollution by US EPA

Planned changes could mean weaker emission controls for chemical industry




ir

How ACS local sections are supporting their communities during COVID-19

ACS local sections and members are gathering lab equipment, making chemistry-themed face masks, and more to pitch in during the pandemic




ir

Video: Mucus inspires sticky, stretchy, antibacterial material

Made with bacteria-killing carvacrol oil, the new substance might be used as an adhesive or coating




ir

During the coronavirus pandemic, hospitals have taken unprecedented steps to disinfect N95 face masks

With protective equipment in short supply, health-care facilities are decontaminating and reusing items designed to be disposable




ir

As they scramble to shore up supplies, small firms brace for a recession

Early signs of a downturn in demand herald a season of unprecedented uncertainty




ir

Gilead's remdesivir gets emergency use authorization based on preliminary data in COVID-19

Limited results from a NIAID study suggest the drug helps people with COVID-19 recover faster




ir

Finding what cells the coronavirus can enter could help explain why it spreads so well

Two studies pinpoint nasal cells and others that express the molecules the virus uses to get inside




ir

BASF and Dow see early coronavirus impacts in first-quarter earnings

Manufacturing shutdowns and oil prices were a drag on results




ir

Making lithium-ion batteries more environmentally friendly

New process uses water-soluble binders to avoid the need for organic solvents in manufacturing and recycling




ir

Podcast: Diagnose, treat, vaccinate—beating a killer coronavirus

<i>Stereo Chemistry</i> looks at lessons learned from previous epidemics and the global effort underway to stop this new microscopic foe




ir

Moderna picks Lonza to make 1 billion doses of its coronavirus vaccine

Program boosts effort by the mRNA therapy pioneer to be first with a coronavirus vaccine




ir

How big pharma firms are quietly collaborating on new coronavirus antivirals

Behind the scenes, companies including Novartis, Takeda, and Gilead are collaborating in a loose alliance. Their work might not be done in time to stop COVID-19, but they hope it can prevent the next pandemic




ir

Vertex signs viral vector R&amp;D pact with Affinia




ir

Mitsubishi will acquire materials firm Gelest




ir

How structural biologists revealed the new coronavirus's structure so quickly

Scientists detail the steps they took to determine the structures of SARS-CoV-2's proteins and the next steps toward COVID-19 treatments




ir

Cancer risk studies raise questions about the safety of long-lasting hair dyes

Long-lasting hair dyes are popular, and their safety has been well researched. But new epidemiology studies show their use correlates with increased risk of breast cancer